Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma

Masaaki Takamura, Takafumi Ichida, Yasunobu Matsuda, Masaaki Kobayashi, Satoshi Yamagiwa, Takuya Genda, Kazuhiko Shioji, Satoru Hashimoto, Minoru Nomoto, Katsuyoshi Hatakeyama, Yoichi Ajioka, Michiie Sakamoto, Setsuo Hirohashi, Yutaka Aoyagi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Liver-intestine cadherin (LI-cadherin) is a recently identified member of the cadherin superfamily. We examined LI-cadherin expression in four human colorectal carcinoma cell lines and 45 human primary colorectal carcinomas using a monoclonal antibody against LI-cadherin. We also investigated the correlation between LI-cadherin expression and clinicopathologic parameters. Among the cell lines, LI-cadherin expression was detected in a differentiated phenotype, but not in dedifferentiated phenotypes. Among the 45 tumor samples, LI-cadherin expression was preserved in 28 (62%) and reduced in 17 (38%). Reduced LI-cadherin expression was significantly associated with a high tumor grade (P=0.015), lymphatic invasion (P=0.033), lymph node metastasis (P=0.015), and an advanced pTNM stage (P=0.033). These results suggest that analysis of LI-cadherin expression may help to indicate the biological aggressiveness of this malignancy.

Original languageEnglish
Pages (from-to)253-259
Number of pages7
JournalCancer Letters
Volume212
Issue number2
DOIs
Publication statusPublished - 2004 Aug 30

Fingerprint

Cadherins
Intestines
Colorectal Neoplasms
Lymph Nodes
Neoplasm Metastasis
Liver
Phenotype
Cell Line
Neoplasms
Monoclonal Antibodies

Keywords

  • Colorectal carcinoma
  • Immunohistochemistry
  • Liver-intestine cadherin
  • Lymph node metastasis
  • monoclonal antibody

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. / Takamura, Masaaki; Ichida, Takafumi; Matsuda, Yasunobu; Kobayashi, Masaaki; Yamagiwa, Satoshi; Genda, Takuya; Shioji, Kazuhiko; Hashimoto, Satoru; Nomoto, Minoru; Hatakeyama, Katsuyoshi; Ajioka, Yoichi; Sakamoto, Michiie; Hirohashi, Setsuo; Aoyagi, Yutaka.

In: Cancer Letters, Vol. 212, No. 2, 30.08.2004, p. 253-259.

Research output: Contribution to journalArticle

Takamura, M, Ichida, T, Matsuda, Y, Kobayashi, M, Yamagiwa, S, Genda, T, Shioji, K, Hashimoto, S, Nomoto, M, Hatakeyama, K, Ajioka, Y, Sakamoto, M, Hirohashi, S & Aoyagi, Y 2004, 'Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma', Cancer Letters, vol. 212, no. 2, pp. 253-259. https://doi.org/10.1016/j.canlet.2004.03.016
Takamura, Masaaki ; Ichida, Takafumi ; Matsuda, Yasunobu ; Kobayashi, Masaaki ; Yamagiwa, Satoshi ; Genda, Takuya ; Shioji, Kazuhiko ; Hashimoto, Satoru ; Nomoto, Minoru ; Hatakeyama, Katsuyoshi ; Ajioka, Yoichi ; Sakamoto, Michiie ; Hirohashi, Setsuo ; Aoyagi, Yutaka. / Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma. In: Cancer Letters. 2004 ; Vol. 212, No. 2. pp. 253-259.
@article{127f320b77d34d959e6bdbd470b53915,
title = "Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma",
abstract = "Liver-intestine cadherin (LI-cadherin) is a recently identified member of the cadherin superfamily. We examined LI-cadherin expression in four human colorectal carcinoma cell lines and 45 human primary colorectal carcinomas using a monoclonal antibody against LI-cadherin. We also investigated the correlation between LI-cadherin expression and clinicopathologic parameters. Among the cell lines, LI-cadherin expression was detected in a differentiated phenotype, but not in dedifferentiated phenotypes. Among the 45 tumor samples, LI-cadherin expression was preserved in 28 (62{\%}) and reduced in 17 (38{\%}). Reduced LI-cadherin expression was significantly associated with a high tumor grade (P=0.015), lymphatic invasion (P=0.033), lymph node metastasis (P=0.015), and an advanced pTNM stage (P=0.033). These results suggest that analysis of LI-cadherin expression may help to indicate the biological aggressiveness of this malignancy.",
keywords = "Colorectal carcinoma, Immunohistochemistry, Liver-intestine cadherin, Lymph node metastasis, monoclonal antibody",
author = "Masaaki Takamura and Takafumi Ichida and Yasunobu Matsuda and Masaaki Kobayashi and Satoshi Yamagiwa and Takuya Genda and Kazuhiko Shioji and Satoru Hashimoto and Minoru Nomoto and Katsuyoshi Hatakeyama and Yoichi Ajioka and Michiie Sakamoto and Setsuo Hirohashi and Yutaka Aoyagi",
year = "2004",
month = "8",
day = "30",
doi = "10.1016/j.canlet.2004.03.016",
language = "English",
volume = "212",
pages = "253--259",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Reduced expression of liver-intestine cadherin is associated with progression and lymph node metastasis of human colorectal carcinoma

AU - Takamura, Masaaki

AU - Ichida, Takafumi

AU - Matsuda, Yasunobu

AU - Kobayashi, Masaaki

AU - Yamagiwa, Satoshi

AU - Genda, Takuya

AU - Shioji, Kazuhiko

AU - Hashimoto, Satoru

AU - Nomoto, Minoru

AU - Hatakeyama, Katsuyoshi

AU - Ajioka, Yoichi

AU - Sakamoto, Michiie

AU - Hirohashi, Setsuo

AU - Aoyagi, Yutaka

PY - 2004/8/30

Y1 - 2004/8/30

N2 - Liver-intestine cadherin (LI-cadherin) is a recently identified member of the cadherin superfamily. We examined LI-cadherin expression in four human colorectal carcinoma cell lines and 45 human primary colorectal carcinomas using a monoclonal antibody against LI-cadherin. We also investigated the correlation between LI-cadherin expression and clinicopathologic parameters. Among the cell lines, LI-cadherin expression was detected in a differentiated phenotype, but not in dedifferentiated phenotypes. Among the 45 tumor samples, LI-cadherin expression was preserved in 28 (62%) and reduced in 17 (38%). Reduced LI-cadherin expression was significantly associated with a high tumor grade (P=0.015), lymphatic invasion (P=0.033), lymph node metastasis (P=0.015), and an advanced pTNM stage (P=0.033). These results suggest that analysis of LI-cadherin expression may help to indicate the biological aggressiveness of this malignancy.

AB - Liver-intestine cadherin (LI-cadherin) is a recently identified member of the cadherin superfamily. We examined LI-cadherin expression in four human colorectal carcinoma cell lines and 45 human primary colorectal carcinomas using a monoclonal antibody against LI-cadherin. We also investigated the correlation between LI-cadherin expression and clinicopathologic parameters. Among the cell lines, LI-cadherin expression was detected in a differentiated phenotype, but not in dedifferentiated phenotypes. Among the 45 tumor samples, LI-cadherin expression was preserved in 28 (62%) and reduced in 17 (38%). Reduced LI-cadherin expression was significantly associated with a high tumor grade (P=0.015), lymphatic invasion (P=0.033), lymph node metastasis (P=0.015), and an advanced pTNM stage (P=0.033). These results suggest that analysis of LI-cadherin expression may help to indicate the biological aggressiveness of this malignancy.

KW - Colorectal carcinoma

KW - Immunohistochemistry

KW - Liver-intestine cadherin

KW - Lymph node metastasis

KW - monoclonal antibody

UR - http://www.scopus.com/inward/record.url?scp=3242886110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242886110&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2004.03.016

DO - 10.1016/j.canlet.2004.03.016

M3 - Article

C2 - 15279905

AN - SCOPUS:3242886110

VL - 212

SP - 253

EP - 259

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -